Gabelli Downgrades Diebold (DBD) to Hold following Q3; Risks Ahead

October 26, 2012 10:15 AM

Gabelli downgraded Diebold (NYSE: DBD) from Buy to Hold with a price target of $47.00 (from $54.00) due to operational ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found